Gene Therapy Cures Pain in 27 of 28 Sickle Cell Patients

A groundbreaking gene therapy trial has achieved what doctors call a "functional cure" for sickle cell disease, eliminating painful crises in 27 out of 28 patients.

The one-time treatment uses gene editing to fix the blood disorder that has killed patients decades too soon.